These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1517556

  • 1. Serotonergic probes in obsessive compulsive disorder.
    Zohar J, Kindler S.
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():39-40. PubMed ID: 1517556
    [No Abstract] [Full Text] [Related]

  • 2. The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder.
    Goodman WK, McDougle CJ, Price LH.
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():35-8. PubMed ID: 1517555
    [No Abstract] [Full Text] [Related]

  • 3. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 4. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J.
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [Abstract] [Full Text] [Related]

  • 5. Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
    Mattes JA.
    Am J Psychiatry; 1994 Oct; 151(10):1524. PubMed ID: 8092352
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK, McDougle CJ, Price LH.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [Abstract] [Full Text] [Related]

  • 7. Are effective antiobsessional drugs interchangeable?
    Tamimi RR, Mavissakalian MR.
    Arch Gen Psychiatry; 1991 Sep; 48(9):857-9. PubMed ID: 1929778
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW, Morton WA, Lydiard RB.
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [Abstract] [Full Text] [Related]

  • 9. Animal models in obsessive compulsive disorder.
    Olivier B.
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():27-9. PubMed ID: 1517553
    [No Abstract] [Full Text] [Related]

  • 10. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL.
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [Abstract] [Full Text] [Related]

  • 11. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
    Hanna GL, McCracken JT, Cantwell DP.
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):173-8. PubMed ID: 2016218
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M, Pini S, Bellantuono C, Wilkinson G.
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [Abstract] [Full Text] [Related]

  • 13. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA, Bullock T, Fineberg N.
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract] [Full Text] [Related]

  • 14. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia.
    Kopala L, Honer WG.
    Am J Psychiatry; 1994 Nov; 151(11):1714-5. PubMed ID: 7524373
    [No Abstract] [Full Text] [Related]

  • 15. Drug-induced mania.
    Mundo E, Ronchi P, Bellodi L.
    Hosp Community Psychiatry; 1993 Jul; 44(7):689-90. PubMed ID: 8354514
    [No Abstract] [Full Text] [Related]

  • 16. Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.
    Stein DJ, Hollander E, Anthony DT, Schneier FR, Fallon BA, Liebowitz MR, Klein DF.
    J Clin Psychiatry; 1992 Aug; 53(8):267-71. PubMed ID: 1386848
    [Abstract] [Full Text] [Related]

  • 17. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL.
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [Abstract] [Full Text] [Related]

  • 18. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [Abstract] [Full Text] [Related]

  • 19. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 20. Neurobiology of obsessive compulsive disorder.
    Insel TR, Winslow JT.
    Psychiatr Clin North Am; 1992 Dec; 15(4):813-24. PubMed ID: 1461798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.